NioCorp 8-K Details 15-Year Traxys Offtake: 50% Ferroniobium Take-or-Pay, All Other Products Exclusive
NB is trading near its 52-week low of $3.03 (4.6% above the low).
Summary
NioCorp filed the full terms of its 15-year Traxys offtake: take-or-pay for 50% of ferroniobium output plus exclusive marketing rights to all other Elk Creek products, replacing the 2016 agreement. The deal is contingent on EXIM Bank financing approval or financial close by December 31, 2027.
Key Events · M&A and Partnerships · NB
-
15-Year Traxys Offtake Signed
Elk Creek Resources Corp. entered the Offtake Agreement on October 13, 2026; Traxys will buy 50% of annual ferroniobium production on a take-or-pay basis, or 3,700 metric tonnes per year at its election, with a right of first refusal on additional ferroniobium.
-
Exclusive Marketing for All Other Products
Traxys holds the exclusive right, but not the obligation, to market and sell 100% of Elk Creek's non-ferroniobium output — scandium oxide, scandium metal, scandium-aluminum master alloy, titanium tetrachloride, NdPr oxide, dysprosium oxide, terbium oxide, samarium-europium-gadolinium carbonate and heavy rare earth carbonate.
-
Pricing Tied to Market, Discount Widens
Ferroniobium is priced off a published monthly market price less a discount that increases at five-year intervals; Other Products are priced off published assessments or Traxys' invoiced third-party gross price, less a marketing commission and Traxys' actual logistics, marketing and financing costs.
-
EXIM Financing Is the Off-Ramp
Either party may terminate if the Export-Import Bank of the United States has not given final approval of senior debt financing, or financial close has not occurred, by December 31, 2027, with a six-month extension if approval is obtained but close is pending; Traxys may also terminate if commercial production has not begun within 60 months of execution.
Analysis · NB · Energy & Transportation
This 8-K puts the full contract behind the Traxys deal announced October 13. Traxys commits to buy 50% of Elk Creek's annual ferroniobium output on a take-or-pay basis (or 3,700 tonnes/year at its election) for 15 years from commercial production, and gets the exclusive right to market 100% of everything else the project produces — scandium, titanium tetrachloride and the rare earths. That is a committed buyer for the entire planned product suite, which is what a project needing roughly $1.85B in capex (per the September 10-K) needs to show lenders. The catch is timing: either side can walk if the Export-Import Bank has not given final approval of senior debt financing, or financial close has not happened, by December 31, 2027, and Traxys can exit if commercial production has not started within 60 months. So the offtake is real revenue visibility, but it is contingent on financing that has not yet closed — and the stock is trading near its 52-week low of $3.03 against a $9.98 high, which tells you the market is still pricing construction and funding risk, not the offtake itself.
How filings like this one have moved
In the 30 days to Oct 31, 2026, 31.5% of the 1750 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NB was trading at $3.17 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $455.8M. The 52-week trading range was $3.03 to $9.98. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.